Arpraziquantel
Formulations: - Oral > Solid > dispersible tablet: 150 mg Indications: - Schistosomiasis Source: EML workbook import

Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
Formulations: - Oral > Solid > dispersible tablet: 150 mg Indications: - Schistosomiasis Source: EML workbook import
Formulations: - Oral > Liquid: 250 mg per 5 mL Oral > Solid > capsule: 250 mg Indications: - Schistosomiasis due to Schistosoma mansoni Source: EML workbook import
Formulations: - Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg Indications: - Paragonimiasis - Clonorchiasis - Opisthorchiasis - Schistosomiasis - Cysticercosis of central nervous system - Diphyllobothriasis - Taeniasis due to Taenia saginata - Taeniasis due to Taenia solium - Hymenolepiasis Source: EML workbook import
Formulations: - Oral > Solid > tablet: 250 mg (scored) Indications: - Paragonimiasis - Fascioliasis Source: EML workbook import
Formulations: - Oral > Liquid: 100 mg per 5 mL Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 100 mg (chewable); 200 mg (chewable); 400 mg (scored) - Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 400 mg - Oral > Liquid: 100 mg per 5 mL Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 100 mg (chewable); 200 mg (chewable); 400 mg (scored) Oral > Solid > capsule: 100 mg (extended-release); 200 mg (extended-release); 300 mg (extended-release) Indications: - Epilepsy or seizures - Bipolar or related disorders - Trigeminal neuralgia Source: EML workbook import
Formulations: - Local > Rectal > Gel: 5 mg per mL in 0.5 mL rectal delivery system; 5 mg per mL in 2 mL rectal delivery system; 5 mg per mL in 4 mL rectal delivery system Local > Rectal > Solution: 2 mg per mL in 1.25 mL rectal tube; 2 mg per mL in 2.5 mL rectal tube; 4 mg per mL in 2.5 mL rectal tube - Oral > Solid: 5 mg (scored); 2 mg (scored) - Oral > Liquid: 2 mg per 5 mL Local > Rectal > Gel: 5 mg per mL in 0.5 mL rectal delivery system; 5 mg per mL in 2 mL rectal delivery system; 5 mg per mL in 4 mL rectal delivery system Local > Rectal > Solution: 2 mg per mL in 1.25 mL rectal tube; 2 mg per mL in 2.5 mL rectal tube; 4 mg per mL in 2.5 mL rectal tube Parenteral > General injections > unspecified: 5 mg per mL Oral > Solid > tablet: 5 mg (scored); 10 mg (scored); 2 mg (scored) Indications: - Status epilepticus - Anxiety - Palliative care Source: EML workbook import
Formulations: - Oral > Liquid: 250 mg per 5 mL Oral > Solid: 250 mg Indications: - Absence seizures, typical Source: EML workbook import
Formulations: - Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet; 200 mg tablet; 2 mg tablet (chewable, dispersible); 5 mg tablet (chewable, dispersible); 25 mg tablet (chewable, dispersible); 50 mg tablet (chewable, dispersible); 100 mg tablet (chewable, dispersible); 200 mg tablet (chewable, dispersible) Indications: - Epilepsy or seizures Source: EML workbook import
Formulations: - Oral > Liquid: 100 mg per mL Oral > Solid > tablet: 250 mg; 500 mg; 750 mg; 1000 mg Parenteral > General injections > IV: 100 mg per mL in 5 mL ampoule or vial; 5 mg per mL in 100 mL bag; 10 mg per mL in 100 mL bag; 15 mg per mL in 100 mL bag Indications: - Epilepsy or seizures - Status epilepticus Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 500 mg per mL in 2 mL ampoule (equivalent to 1 g in 2 mL; 50% weight/volume) Parenteral > General injections > IM: 500 mg per mL in 10 mL ampoule (equivalent to 5 g in 10 mL; 50% weight/volume) Indications: - Severe pre-eclampsia - Eclampsia Source: EML workbook import
Formulations: - Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial (for buccal administration); 5 mg per mL in 1 mL vial (for buccal administration); 5 mg per mL in 3 mL vial (for buccal administration) Local > Buccal > Solution: 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.75 mL pre-filled syringe; 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) - Oral > Liquid: 2 mg per mL Parenteral > General injections > unspecified: 1 mg per mL in 5 mL vial; 5 mg per mL in 1 mL vial; 5 mg per mL in 3 mL vial Local > Buccal > Solution: ; 5 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 0.75 mL pre-filled syringe (for oromucosal administration); 10 mg per mL in 1 mL pre-filled syringe (for oromucosal administration) Oral > Solid > dosage form: 7.5 mg; 15 mg - Parenteral > General injections > IV: 1 mg per mL in 5 vial; 5 mg per mL in 1 mL vial; 5 mg per mL in 3 mL vial Oral > Liquid: 2 mg per mL Oral > Solid > dosage form: 15 mg; 7.5 mg Indications: - Status epilepticus - Palliative care - Sedative-hypnotic and anxiolytic drugs Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.